carbachol has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chotirat, S | 1 |
| Suriyo, T | 1 |
| Hokland, M | 1 |
| Hokland, P | 1 |
| Satayavivad, J | 1 |
| Auewarakul, CU | 1 |
1 other study available for carbachol and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Cholinergic activation enhances retinoic acid-induced differentiation in the human NB-4 acute promyelocytic leukemia cell line.
Topics: Acetylcholine; Carbachol; Caspase 3; Cell Differentiation; Cell Line, Tumor; Cholinergic Agents; Hum | 2016 |